Scinovex
article Open Access

Melasma assessment of quality of life among Iraqi women during 2023

International Journal of Dermatology Sciences · 2024 · Vol. 6(1) · pp. 01–08

Abstract

Background: Melasma is an acquired pigmentary disorder that has a negative impact on various domains of patient’s quality of life. Measurement of quality of life can help in enhancing patients care and outcomes. Objectives: To assess the impact on the quality of life in Iraqi women with Melasma and to find if there is any association between quality of life and certain study variable. Patients and Methods: A cross-sectional study was conducted among convenient sample of 100 Melasma women patients, attending the dermatology clinic, Al-Yarmook Teaching hospital. Data was collected using The Melasma Quality of Life Scale (MELASQOL). The data analyzed using Statistical Package for Social Sciences (SPSS) version 27. Chi-square test was used for categorical data and Kruskal-Wallis test for non-parametric comparison of mean. Results: In this study, women with secondary school education (22%), housewives (29%) and resides in urban area (23%) tends to have good quality of life. Moreover, Melasma patients who didn’t take OCP (35%) and exposed to sun for leisure (29%) tends to have good quality of life. No statistically significant difference was detected between patients’ quality of life with duration of sun exposure, age of onset of Melasma and duration of disease. Conclusions: Education, occupation, residency, OCP use, and sun exposure had a significant impact on patients’ quality of life.

Skin Protection and AgingDermatologic Treatments and ResearchCutaneous Melanoma Detection and ManagementMelasmaMedicineQuality of life (healthcare)Test (biology)DermatologyGerontologyNursing
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
1%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Melasma assessment of quality of life among Iraqi women during 2023 · Scinovex